Cell-free Protein Expression: Worldwide Market Analysis & Outlook to 2023 featuring Thermo Fisher Scientific, Takara Bio, Qiagen, Promega Corp, Bioneer Corp, and many more - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Oct 11, 2018--The “Global Cell-free Protein Expression Market - Segmented by Product (Accessories and Consumables, and Lysate Systems), By Application, By End User, and By Geography- Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.The cell-free protein expression market is expected to register a CAGR of 6.1% over the forecast period.
Advantages such as shorter expression time and structural modification are contributing to market growth. Other factors which are contributing to the market growth include increasing R&D in the field of proteomics & genomics and high prevalence of cancer & infectious diseases.
Lack of efficient systems for post-translational modifications is limiting market growth. Other factors that could potentially impede the growth of the market include high costs of cell-free protein expression kits.
In 2017, North America was the largest regional market in terms of revenue. The increasing prevalence of chronic diseases such as cancer, aging population, growing demand for targeted and personalized medicine, the presence of major R&D facilities, and favorable government initiatives are major factors contributing to the large market size.
Major Market DevelopmentsLenioBio GmbH and Fraunhofer IME announced an exclusive license agreement for Fraunhofer’s proprietary vector solution for the cryopreservation of cell lysates, and LenioBio GmbH revealed plans to launch its expression kit under the brand name ALiCE.Companies ProfiledBioneer Corporationbiotechrabbit GmbHCellFree Sciences Co. Ltd.Cube Biotech GmbHGeneCopoeia Inc.Jena Bioscience GmbHNew England Biolabs Ltd.Promega CorporationQiagen N.V.Sigma-Aldrich Corporation (Merck KGaA)Takara Bio Inc.Thermo Fisher Scientific Inc.
Key Topics Covered
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Market Dynamics
7. Market Segmentation
8. Company Profiles and Competitive Landscape
9. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/f65vm2/cellfree_protein?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181011005440/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 10/11/2018 08:50 AM/DISC: 10/11/2018 08:50 AM